Glutamine + glutamate level predicts the magnitude of microstructural organization in the gray matter in the healthy elderly.


Journal

International psychogeriatrics
ISSN: 1741-203X
Titre abrégé: Int Psychogeriatr
Pays: England
ID NLM: 9007918

Informations de publication

Date de publication:
01 2021
Historique:
pubmed: 4 10 2019
medline: 26 10 2021
entrez: 4 10 2019
Statut: ppublish

Résumé

Diffusion tensor imaging (DTI), which is a technique for measuring the degree and direction of movement of water molecules in tissue, has been widely used to noninvasively assess white matter (WM) or gray matter (GM) microstructures in vivo. Mean diffusivity (MD), which is the average diffusion across all directions, has been considered as a marker of WM tract degeneration or extracellular space enlargement in GM. Recent lines of evidence suggest that cortical MD can better identify early-stage Alzheimer's disease than structural morphometric parameters in magnetic resonance imaging. However, knowledge of the relationships between cortical MD and other biological factors in the same cortical region, e.g. metabolites, is still limited. Thirty-three healthy elderly individuals [aged 50-77 years (mean, 63.8±7.4 years); 11 males and 22 females] were enrolled. We estimated the associations between cortical MD and neurotransmitter levels. Specifically, we measured levels of γ-aminobutyric acid (GABA) and glutamate + glutamine (Glx), which are inhibitory and excitatory neurotransmitters, respectively, in medial prefrontal cortex (mPFC) and posterior cingulate cortex (PCC) using MEGA-PRESS magnetic resonance spectroscopy, and we measured regional cortical MD using DTI. Cortical MD was significantly negatively associated with Glx levels in both mPFC and PCC. No significant association was observed between cortical MD and GABA levels in either GM region. Our findings suggest that degeneration of microstructural organization in GM, as determined on the basis of cortical MD measured by DTI, is accompanied by the decline of Glx metabolism within the same GM region.

Sections du résumé

BACKGROUND
Diffusion tensor imaging (DTI), which is a technique for measuring the degree and direction of movement of water molecules in tissue, has been widely used to noninvasively assess white matter (WM) or gray matter (GM) microstructures in vivo. Mean diffusivity (MD), which is the average diffusion across all directions, has been considered as a marker of WM tract degeneration or extracellular space enlargement in GM. Recent lines of evidence suggest that cortical MD can better identify early-stage Alzheimer's disease than structural morphometric parameters in magnetic resonance imaging. However, knowledge of the relationships between cortical MD and other biological factors in the same cortical region, e.g. metabolites, is still limited.
METHODS
Thirty-three healthy elderly individuals [aged 50-77 years (mean, 63.8±7.4 years); 11 males and 22 females] were enrolled. We estimated the associations between cortical MD and neurotransmitter levels. Specifically, we measured levels of γ-aminobutyric acid (GABA) and glutamate + glutamine (Glx), which are inhibitory and excitatory neurotransmitters, respectively, in medial prefrontal cortex (mPFC) and posterior cingulate cortex (PCC) using MEGA-PRESS magnetic resonance spectroscopy, and we measured regional cortical MD using DTI.
RESULTS
Cortical MD was significantly negatively associated with Glx levels in both mPFC and PCC. No significant association was observed between cortical MD and GABA levels in either GM region.
CONCLUSION
Our findings suggest that degeneration of microstructural organization in GM, as determined on the basis of cortical MD measured by DTI, is accompanied by the decline of Glx metabolism within the same GM region.

Identifiants

pubmed: 31578159
pii: S1041610219001418
doi: 10.1017/S1041610219001418
pmc: PMC8482373
doi:

Substances chimiques

Glutamine 0RH81L854J
Glutamic Acid 3KX376GY7L

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

21-29

Commentaires et corrections

Type : CommentIn

Références

J Magn Reson Imaging. 2008 Jan;27(1):20-6
pubmed: 18050329
Radiology. 1986 Nov;161(2):401-7
pubmed: 3763909
NMR Biomed. 2001 Jun;14(4):233-46
pubmed: 11410941
Nat Neurosci. 2012 Jun 17;15(7):960-1
pubmed: 22706268
Magn Reson Med. 2015 Jan;73(1):44-50
pubmed: 24436292
Alzheimers Res Ther. 2015 Jul 01;7(1):47
pubmed: 26136857
Neuropsychopharmacology. 2013 Jul;38(8):1401-8
pubmed: 23403696
Comput Biol Med. 2001 Jul;31(4):269-86
pubmed: 11334636
Neurobiol Aging. 2008 Jan;29(1):102-16
pubmed: 17023094
Mech Ageing Dev. 2001 Jan;122(1):1-29
pubmed: 11163621
J Neurochem. 2001 Apr;77(1):292-303
pubmed: 11279285
Pol J Radiol. 2016 Jun 19;81:288-94
pubmed: 27429670
Med Image Comput Comput Assist Interv. 2008;11(Pt 1):279-86
pubmed: 18979758
J Magn Reson Imaging. 2001 Apr;13(4):534-46
pubmed: 11276097
IEEE Trans Med Imaging. 2001 Jan;20(1):45-57
pubmed: 11293691
Neurobiol Aging. 2017 Jun;54:103-111
pubmed: 28363111
Schizophr Bull. 2013 Jan;39(1):197-205
pubmed: 21914645
J Alzheimers Dis. 2015;45(1):97-107
pubmed: 25537012
J Psychiatry Neurosci. 2017 May;42(3):150-163
pubmed: 27780031
Cereb Cortex. 2008 Oct;18(10):2241-50
pubmed: 18234683
Neuroimage. 2017 Feb 01;146:90-99
pubmed: 27864081
Neuroradiology. 2004 May;46(5):339-50
pubmed: 15103435
Neuroimage. 2015 Apr 1;109:102-8
pubmed: 25583607
Neuroimage. 2012 Aug 15;62(2):782-90
pubmed: 21979382
J Alzheimers Dis. 2010;21(3):795-811
pubmed: 20634587
Med Sci Monit. 2011 Dec;17(12):MT105-11
pubmed: 22129910
Neurobiol Aging. 2015 Jan;36(1):53-9
pubmed: 25169676
J Stroke Cerebrovasc Dis. 2013 Aug;22(6):737-41
pubmed: 22306380
Eur J Radiol. 2010 Aug;75(2):134-8
pubmed: 19443158
NMR Biomed. 2016 Aug;29(8):1108-16
pubmed: 27351339
J Magn Reson Imaging. 2015 May;41(5):1326-31
pubmed: 24863149
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
Int J Geriatr Psychiatry. 2012 Nov;27(11):1189-94
pubmed: 22228412
Eur Radiol. 2017 Jul;27(7):2698-2705
pubmed: 27966041
Neuroimage. 2004;23 Suppl 1:S208-19
pubmed: 15501092
Biol Psychiatry. 2010 Nov 1;68(9):785-94
pubmed: 20728076
Neurology. 2006 Feb 28;66(4):535-9
pubmed: 16505308
Biol Psychiatry Cogn Neurosci Neuroimaging. 2017 Jan;2(1):38-44
pubmed: 28217759
Neuropsychologia. 1971 Mar;9(1):97-113
pubmed: 5146491
J Biosci. 2016 Sep;41(3):419-26
pubmed: 27581933
Radiology. 2006 Oct;241(1):197-205
pubmed: 16990677
J Neurol. 2016 Jun;263(6):1146-55
pubmed: 27094571
Neurobiol Aging. 2012 May;33(5):945-59
pubmed: 20724035
Neurobiol Aging. 2008 Nov;29(11):1619-30
pubmed: 17531353
Funct Neurol. 2016 Jan-Mar;31(1):39-46
pubmed: 27027893
Brain Behav. 2015 Jul;5(7):e00334
pubmed: 26221568
Front Aging Neurosci. 2017 Jan 11;8:325
pubmed: 28123367
Neuroimage. 2009 Mar;45(1 Suppl):S173-86
pubmed: 19059349
NMR Biomed. 1998 Oct;11(6):266-72
pubmed: 9802468
Magn Reson Med. 2017 Jan;77(1):23-33
pubmed: 26715192
NMR Biomed. 2002 Nov-Dec;15(7-8):543-52
pubmed: 12489100
NMR Biomed. 2013 Nov;26(11):1353-62
pubmed: 23696182
Psychiatry Clin Neurosci. 2006 Jun;60(3):332-9
pubmed: 16732750
Neurology. 2001 Mar 27;56(6):737-42
pubmed: 11274307
J Alzheimers Dis. 2016 Mar 5;52(1):145-59
pubmed: 27060946
Hum Brain Mapp. 2014 Oct;35(10):5040-5051
pubmed: 24753040
J Neurol Neurosurg Psychiatry. 2007 Sep;78(9):964-9
pubmed: 17449543

Auteurs

Tomokazu Motegi (T)

Department of Psychiatry and Neuroscience, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan.

Kosuke Narita (K)

Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, Japan.

Kazuyuki Fujihara (K)

Department of Psychiatry and Neuroscience, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan.

Masato Kasagi (M)

Department of Psychiatry and Neuroscience, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan.

Yusuke Suzuki (Y)

Department of Psychiatry and Neuroscience, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan.

Minami Tagawa (M)

Department of Psychiatry and Neuroscience, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan.

Koichi Ujita (K)

Department of Diagnostic Radiology and Nuclear Medicine, Gunma University Graduate School of Medicine, Maebashi, Gunma 371-8511, Japan.

Jamie Near (J)

Douglas Mental Health University Institute and Department of Psychiatry, McGill University, Montreal, QC, Canada.

Masato Fukuda (M)

Department of Psychiatry and Neuroscience, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH